3554 results for «2292»

Filter By

3554 results

Mitral interventions - part 2: Global EXPAND registry

25 Jun 2020 – From PCR e-Course 2020

Watch this session to find out more on clip selection strategy and the safety and effectiveness of the MitraClip XTR System: Results and recommendations from the Global EXPAND Study.

This session was originally presented during PCR e-Course 2020.

Mitral interventions - Global EXPAND registry

PCR e-Course 2020 Late-Breaking Trials - part 2

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice: 

  • 2-year safety of revascularisation deferral based on iFR or FFR
  • CABG and PCI in patients with CTO and multivessel disease
  • Routine revascularisation vs. medical therapy
PCR e-Course 2020 Late-Breaking Trials

PCR e-Course Hot Lines in STEMI interventions: First-in-Man and novel pharmacological strategies

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines in STEMI interventions presented during PCR e-Course 2020, followed by an analysis of these results and their impact on your practice: MOCA I Study, ON-TIME 3 trial, FABOLUS FASTER.

STEMI interventions: First-in-Man and novel pharmacological strategies

PCR e-Course Hot lines: drugs and devices for STEMI management

Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.

Hot line: drugs and devices for STEMI management

Physiology or intracoronary imaging; or both? or none? - part 1

27 Jun 2020 – From PCR e-Course 2020

Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.

Physiology or intracoronary imaging; or both? or none?

PCR e-Course 2020 Hot line: left atrial appendage closure

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on LAA closure presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: LAA occlusion vs. NOAC, Amulet IDE Roll-in cohort, identification of potential LAAC candidates.

PCR e-Course Hot lines: left atrial appendage closure

Physiology or intracoronary imaging; or both? or none? - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SOCT-PCI Study, impact of PPG index on PCI, angiography-derived IMR.

Physiology or intracoronary imaging; or both? or none?

Hot line on PCI: high bleeding risk and DAPT - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: TWILIGHT CHINA, SMART-CHOICE, LEADERS FREE III.

Hot lines on PCI: high bleeding risk and DAPT

Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation

25 Jun 2020 – From PCR e-Course 2020

A  common  exclusion  for  transcatheter  mitral  valve  implantation  (TMVI)  is  a  small  predicted  neo-left  ventricular  outflow  tract  (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...

LVESD screening determines anatomic suitability for TMVI

New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection

26 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.

New TMVI Therapy to eliminate mitral regurgitation: evidence and patient selection

Everything you should know to perform a transcatheter valve in valve procedure

22 Nov 2020 – From PCR Valves e-course 2020

Watch this session if you want to understand what are the key criteria to be considered when choosing a THV, especially in patients with expected longer life expectancy, to learn about how to successfully perform Valve-in-surgical-valve procedures and to understand about key procedural aspects to consider...

Everything you should

Tricuspid percutaneous repair

22 Nov 2020 – From PCR Valves e-Course 2020

Learn more about combined percutaneous mitral and tricuspid repair as well as percutaneous repair of isolated tricuspid regurgitation using MitraClip.

Tricuspid percutaneous repair

TAVI vascular access: Part 1

22 Nov 2020 – From PCR Valves e-Course 2020

Discover a selection of TAVI vascular access cases: lithotripsy of iliac artery and TAVI using a self-expandable valve, shockwave-assisted transfemoral TAVI via the last available femoral route

TAVI vascular access: Part 1

TAVI Valve-in-valve: Aortic

22 Nov 2020 – From PCR Valves e-Course 2020

Discover various TAVI Valve-in-valve cases: transcatheter treatment of a degenerated sutureless valve using self-expandable prosthesis, emergency TAVI in TAVI for treatment of unexpected prosthetic valve dysfunction, and more!

TAVI Valve-in-valve: Aortic

TAVI Valve-in-valve

22 Nov 2020 – From PCR Valves e-Course 2020

Discover a selection of TAVI Valve-in-valve cases: undeployed coronary stent in LM artery for high-risk transcatheter aortic ViV, self-expandable TAVI ViV in a high surgical risk patient with severe prosthetic valve dysfunction, and more!

TAVI Valve-in-valve

TAVI in no aortic position

22 Nov 2020 – From PCR Valves e-Course 2020

Discover a selection of TAVI cases: Transcatheter mitral ViV implantation in a history of prior quadruple bioprosthetic valve replacement for rheumatic valvular heart disease, transcatheter tricuspid ViV replacement using next-generation balloon-expandable THV system, and more!

TAVI in no aortic position

TAVI in mitral

22 Nov 2020 – From PCR Valves e-Course 2020

Learn more about TAVI in mitral and valve-in-mitral annular calcification (ViMAC) with this case.

TAVI in mitral

TAVI in challenging scenarios: patients with previous surgery on aortic root

22 Nov 2020 – From PCR Valves e-Course 2020

Discover a selection of challenging TAVI cases: TAVI in failed Bio-Bentall with severe AR and no accompanying stenosis in a high-risk patient, TAVI after valve sparing aortic root replacement, and more!

TAVI in challenging scenarios: patients with previous surgery on aortic root

TAVI in challenging scenarios: patients with aortic regurgitation

22 Nov 2020 – From PCR Valves e-Course 2020

Discover various cases of TAVI in challenging scenarios: Transfemoral aortic valve implantation in the case of pre-existing mitral prosthesis and pure AR, High-risk patient with severe AR treated with self-expandable TAVI, and more!

TAVI in challenging scenarios: patients with aortic regurgitation

TAVI in challenging scenarios: Part 1

22 Nov 2020 – From PCR Valves e-Course 2020

Discover various cases of TAVI in challenging scenarios, such as TAVI with a novel balloon expandable valve for rheumatic AS in a patient with a prosthetic mitral valve, TAVI with a novel pre-packaged self-expandable dry-tissue transcatheter aortic valve, and more!

TAVI in challenging scenarios: Part 1
Didn’t find what you were looking for?